DKSH tapped as distributor of Medigen’s COVID-19 vaccines
Its cold chain solutions services include storage, distribution, and delivery.
DKSH Business Unit Healthcare has been selected to provide a vaccine cold chain solution for Taiwan-based biopharmaceutical company Medigen Vaccine Biologics Corporation.
In a statement, DKSH said it will be providing storage in a two-to-eight-degree Celsius environment for Medigen’s vaccines in its brand-new cold chain facility, along with a dedicated healthcare delivery team across Taiwan.
The services included in the partnership include storage, distribution, delivery, and other value-added services such as labelling and repackaging.
The facility has been certified by the Ministry of Health and Welfare’s Pharmaceutical Inspection Co-operation Scheme for Good Manufacturing and Distribution Practices licenses “to ensure the quality of the product is protected throughout the entire supply chain process.
“With a highly professional, dedicated team and an extensive healthcare supply chain network covering hospitals, clinics and all levels of healthcare service outlets, we are confident that DKSH will speedily and reliably deliver the vaccine to the right locations for people to be vaccinated in a timely manner,” Leo Lee, executive vice president of Medigen, said, adding that DKSH Taiwan has been providing service to healthcare industry for over 20 years.